Results 11 to 20 of about 213,106 (383)

Low NT‐proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction [PDF]

ESC Heart Failure, 2018
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome that presents clinicians with a diagnostic challenge. The use of natriuretic peptides to exclude a diagnosis of HFpEF has been proposed.
L. Buckley, J. Canada, M. D. Del Buono, S. Carbone, C. Trankle, Hayley E. Billingsley, D. Kadariya, R. Arena, B. V. Van Tassell, A. Abbate   +9 more
semanticscholar   +3 more sources

Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes? [PDF]

, 2009
BACKGROUND: NT-proBNP has prognostic implications in heart failure. In acute coronary syndromes (ACS) setting, the prognostic significance of NT-proBNP is being sought.
Ana Teresa Timóteo, Alexandra Toste, Rúben Ramos, Fernando Pellon de Miranda, Maria Lurdes Ferreira, José Alberto Oliveira, Rui Cruz Ferreira   +6 more
openalex   +3 more sources

NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis

International Journal of COPD, 2023
Purpose NT-proBNP, a peptide biomarker synthesized and secreted by cardiomyocytes in response to cardiac load, has gained attention in recent years for its potential role in respiratory diseases.
Xiaojie Su, Ting Lei, Haichuan Yu, Lu-Miao Zhang, Zhouzhou Feng, Tian-kui Shuai, Hong Guo, Jian Liu   +7 more
semanticscholar   +1 more source

Periprocedural changes in natriuretic peptide levels and clinical outcome after transcatheter mitral valve repair

ESC Heart Failure, 2021
Aims This multicentre study investigated the association of periprocedural changes in the levels of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) with clinical outcomes after transcatheter edge‐to‐edge mitral valve repair (TMVR).
Tetsu Tanaka, Refik Kavsur, Maximilian Spieker, Christos Iliadis, Clemens Metze, Patrick Horn, Atsushi Sugiura, Malte Kelm, Stephan Baldus, Georg Nickenig, Ralf Westenfeld, Roman Pfister, Marc Ulrich Becher   +12 more
doaj   +1 more source

Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort

Circulation: Heart Failure, 2022
Background: Demographic differences in expected NT-proBNP (N-terminal pro-B-type natriuretic peptide) concentration are not well established. We aimed to establish reference ranges for NT-proBNP and explore the determinants of moderately elevated NT ...
P. Welsh, R. Campbell, Leanne Mooney, D. Kimenai, C. Hayward, A. Campbell, D. Porteous, N. Mills, N. Lang, M. Petrie, J. Januzzi, J. McMurray, N. Sattar   +12 more
semanticscholar   +1 more source

Effect of body mass index on N-terminal pro-brain natriuretic peptide values in patients with heart failure

The Egyptian Heart Journal, 2023
Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker used for the diagnosis of heart failure. There is a relationship between NT-proBNP levels and body mass index (BMI). The study aimed to explore the impact of BMI on NT-proBNP
Tuan Ha Manh, Duong Do Anh, Tung Le Viet
doaj   +1 more source

Age-Dependent Reference Values for hs-Troponin T and NT-proBNP and Determining Factors in a Cohort of Healthy Children (The LIFE Child Study)

Pediatric Cardiology, 2022
This study aimed to provide reliable pediatric reference values for N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitive Troponin T (hsTnT) obtained from a population of well children and investigate for associations with sex, pubertal
Alexandra Kiess, J. Green, A. Willenberg, U. Ceglarek, I. Dähnert, A. Jurkutat, A. Körner, A. Hiemisch, W. Kiess, M. Vogel   +9 more
semanticscholar   +1 more source

Characterization of NT‐proBNP in a large cohort of COVID‐19 patients

European Journal of Heart Failure, 2021
Extensive research regarding the association of troponin and prognosis in coronavirus disease 2019 (COVID‐19) has been performed. However, data regarding natriuretic peptides are scarce.
J. Caro-Codón, Juan R. Rey, A. Buño, A. Iniesta, S. Rosillo, Sergio Castrejón-Castrejón, L. Rodríguez‐Sotelo, L. Martinez, I. Marco, C. Merino, L. Martín-Polo, Jose M. García‐Veas, M. Martínez-Cossiani, Luis Gonzalez‐Valle, A. Herrero, E. Lopez-de-Sa, J. L. Merino   +16 more
semanticscholar   +1 more source

The Ratio of NT-proBNP to CysC1.53 Predicts Heart Failure in Patients With Chronic Kidney Disease

Frontiers in Cardiovascular Medicine, 2021
Background: The N-terminal pro B type natriuretic peptide (NT-proBNP) is important for prognosis of heart failure in patients with chronic kidney disease (CKD).
Sheng Wang, Ming Li, Xiangyu Wang, Jing Luo, Yulin Zou, Yang Hu, Xingtai Liu, Hua Ao, Xueer Yao, Chufeng Li, Tingting Yang   +10 more
doaj   +1 more source

Prognostic value of RDW alone and in combination with NT‐proBNP in patients with heart failure

Clinical Cardiology, 2022
Red blood cell distribution width (RDW) and N‐terminal pro brain natriuretic peptide (NT‐proBNP) may predict the prognosis of heart failure (HF). However, the impact of combined RDW and NT‐proBNP levels as a prognostic marker of HF remains unclear and ...
L. Liang, Liyan Huang, Xue-yan Zhao, Lang Zhao, P. Tian, B. Huang, Jiayu Feng, Jian Zhang, Yuhui Zhang   +8 more
semanticscholar   +1 more source